Development of a Mammalian Cell Line for Stable Production of Anti-PD-1

Development of a Mammalian Cell Line for Stable Production of Anti-PD-1

<b>Background/Objectives:</b> Immune checkpoint blockade, particularly targeting the programmed cell death 1 (PD-1) receptor, is a promising strategy in cancer immunotherapy. The interaction between PD-1 and its ligands, PD-L1 and PD-L2, is crucial in immune evasion by tumors. Blocking t...

Full description

Saved in:
Bibliographic Details
Main Authors: Erika Csató-Kovács, Pál Salamon, Szilvia Fikó-Lászlo, Krisztina Kovács, Alice Koka, Mónika András-Korodi, Emőke Antal, Emília Brumă, Brigitta Tőrsők, Szilárd Gudor, Ildikó Miklóssy, Kálmán Csongor Orbán, Csilla Albert, Emese Éva Bálint, Beáta Albert
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Antibodies
Subjects:
immune checkpoint molecule
anti-PD-1
CHO DG44
Nivolumab
monoclonal antibody production
Online Access:https://www.mdpi.com/2073-4468/13/4/82
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items